Clinical trial
A Study of HB0017 Injection to Investigate PK After Subcutaneous Administration at Different Injection Sites in Healthy Volunteers, and to Evaluate Its Safety, Tolerability, and Pharmacokinetics in Low-body-weight Healthy Subjects
NCT07920861 is registered in ClinicalTrials.gov with Huabo Biopharm Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Study of HB0017 Injection to Investigate PK After Subcutaneous Administration at Different Injection Sites in Healthy Volunteers, and to Evaluate Its Safety, Tolerability, and Pharmacokinetics in Low-body-weight Healthy Subjects
- Lead sponsor
- Huabo Biopharm Co., Ltd.
- Phase
- Phase 1
- Overall status
- Recruiting
- Start date
- January 19, 2026
- Completion date
- February 28, 2027
- Enrollment
- 90 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
ankylosing spondylitis, psoriasis
Arms
As registered; 9 arms.
-
PART1: Group 1,75mg
single-dose, SC, HB0017 75 mg or placebo
-
PART1: Group 2, 150mg
single-dose, SC, HB0017 150 mg or placebo
-
PART1: Group 3, 300mg
single-dose, SC, HB0017 300 mg or placebo
-
PART2: Group 4, 150mg, domen
single-dose, SC at domen, HB0017 150 mg
-
PART2: Group 5, 150mg, upper arms
single-dose, SC at upper arms, HB0017 150 mg
+4 more arms
Primary endpoints
Registered primary outcome measures; 3 primary.
-
Adverse events
PART 1: Number of participants experiencing adverse events as assessed by CTCAE v5.0.
-
Cmax
PART 2:Cmax was the maximum observed plasma concentration directly observed from data. Data analysis by group across injection sites - abdomen, upper arm, thigh - at the same dose.
-
AUCinf
PART 2 : AUCinf was area under the plasma concentration versus time curve (AUC) from time zero (pre-dose) to extrapolated infinite time (0-inf , if data permits).Data analysis by group across injection sites - abdomen, upper arm, thigh - at the same dose.
Lead sponsor's other trials
Huabo Biopharm Co., Ltd., most recent start first.
+9 more trials See the organization page
Similar trials
Same condition (Spondylitis, Ankylosing) and phase, most recent start first.
+13 more trials See the condition page